Literature DB >> 2919895

Side gland of Suncus murinus as a new model of sebaceous gland: 5 alpha-reductase, androgen receptor, and nuclear androgen content in male and female animals.

S Komada1, S Itami, S Kurata, S Takayasu.   

Abstract

The side gland of Suncus murinus is composed of well-developed sebaceous glands in both males and females. We measured the 5 alpha-reductase activity, androgen receptor content, and the intranuclear concentrations of testosterone and dihydrotestosterone in this side gland taking it as a new experimental model of human sebaceous glands. Lineweaver-Burk plot analysis suggested the presence of two classes of 5 alpha-reductase with different Km for testosterone in the homogenate. The enzyme activity was slightly higher in males than in females in the presence of a high concentration of testosterone. The levels of androgen receptors were approximately 40 and 30 fmol/mg protein in the cytosol and nuclei, respectively. The values did not differ significantly between males and females. The intranuclear concentration of dihydrotestosterone in the side gland was higher than that of testosterone in each sex. The intranuclear level of each of these two androgens in the female side gland was comparable to that in the male side gland despite the fact that the serum level of testosterone was much lower in the female. These data clearly indicate that the side gland is a typical target tissue for androgens in the female as well as in the male. Androgens other than testosterone may serve as precursors of dihydrotestosterone in the female side gland.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2919895     DOI: 10.1007/BF00427662

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  32 in total

1.  The sebaceous glands of the hamster; morphological effects of androgens on integumentary structures.

Authors:  J B HAMILTON; W MONTAGNA
Journal:  Am J Anat       Date:  1950-03

2.  Functional characteristics of nuclear 5 alpha-reductase from rat ventral prostate.

Authors:  U Enderle-Schmitt; E Völck-Badouin; J Schmitt; G Aumüller
Journal:  J Steroid Biochem       Date:  1986-08       Impact factor: 4.292

3.  Antiserum to 5alpha-dihydrotestosterone: production, characterization and use in radioimmunoassay.

Authors:  S Bauminger; F Kohen; H R Lindner; A Weinstein
Journal:  Steroids       Date:  1974-10       Impact factor: 2.668

4.  Cytoplasmic and nuclear androgen receptor content of normal and neoplastic human prostates and lymph node metastases of human prostatic adenocarcinoma.

Authors:  S A Shain; R W Boesel; D L Lamm; H M Radwin
Journal:  J Clin Endocrinol Metab       Date:  1980-04       Impact factor: 5.958

5.  A new procedure for the quantitation of nuclear and cytoplasmic androgen receptors.

Authors:  A M Traish; R E Muller; H H Wotiz
Journal:  J Biol Chem       Date:  1981-12-10       Impact factor: 5.157

6.  Aging and tissue androgens.

Authors:  J P Deslypere; A Vermeulen
Journal:  J Clin Endocrinol Metab       Date:  1981-08       Impact factor: 5.958

7.  Mechanisms of action of androgens and antiandrogens: effects of antiandrogens on translocation of cytoplasmic androgen receptor and nuclear abundance of dihydrotestosterone.

Authors:  T W Callaway; N Bruchovsky; P S Rennie; T Comeau
Journal:  Prostate       Date:  1982       Impact factor: 4.104

8.  Skin surface lipid composition, acne, pubertal development, and urinary excretion of testosterone and 17-ketosteroids in children.

Authors:  P E Pochi; J S Strauss; D T Downing
Journal:  J Invest Dermatol       Date:  1977-11       Impact factor: 8.551

9.  Androgen- and estrogen-receptor content in spontaneous and experimentally induced canine prostatic hyperplasia.

Authors:  J Trachtenberg; L L Hicks; P C Walsh
Journal:  J Clin Invest       Date:  1980-05       Impact factor: 14.808

10.  In vitro metabolism of testosterone-4-14C and delta-4-androstene-3,17-dione-4-14C in human skin.

Authors:  E C Gomez; S L Hsia
Journal:  Biochemistry       Date:  1968-01       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.